How blood vessels distinguish between growth and inflammation

· Medical Xpress

by University of Mannheim

edited by Sadie Harley, reviewed by Alexander Pol

Sadie Harley

Scientific Editor

Meet our editorial team
Behind our editorial process

Alexander Pol

Deputy Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

The GIST Add as preferred source


Immunofluorescence microscopy image showing leukocytes (in yellow) migrating into the lungs. The pulmonary vessels are stained magenta, and the alveoli are stained green. Credit: Dr. Miki Kamiyama

The angiopoietin-Tie signaling pathway has long been known to be essential for the maturation and maintenance of healthy blood vessels. It stabilizes the vessel wall and regulates vascular growth during development. At the same time, it plays an important role in inflammation, when blood vessels become activated and immune cells leave the bloodstream and enter the surrounding tissue. How the same signaling pathway can control such different biological functions has remained unclear.

A team led by Dr. Mahak Singhal and Dr. Hellmut Augustin has now found an answer to this question. At the center of the discovery is the vascular receptor Tie1, a protein found almost exclusively on endothelial cells—the cells lining the inner surface of blood vessels. During inflammation, part of the Tie1 receptor is enzymatically cleaved from the cell surface.

The research is published in the Journal of Clinical Investigation.

Blocking cleavage reduces vascular inflammation

To investigate the significance of this process, the researchers generated genetically modified mice in which Tie1 can no longer be cleaved. The animals developed entirely normal blood vessels and showed no detectable abnormalities during development, adulthood or aging. Even under conditions that normally stimulate the formation of new blood vessels, vascular growth remained unchanged.

The picture was different when the mice were exposed to inflammatory stimuli. The genetically modified animals showed a markedly reduced inflammatory response. Their blood vessels were less strongly activated, and substantially fewer immune cells migrated from the bloodstream into the surrounding tissue.

"Our experiments show that Tie1 cleavage is not required for the normal development or maintenance of blood vessels," says first author Dr. Miki Kamiyama. "Rather, it enables blood vessels to respond specifically to inflammatory signals."

The findings therefore show that Tie1 cleavage uncouples two functions of the same signaling pathway: the vessel-stabilizing and vessel-growth-promoting functions of angiopoietin-Tie signaling remain intact when Tie1 is preserved, whereas receptor cleavage is required for its proinflammatory activity.

Endothelial cells control immune cell entry

The study highlights that endothelial cells do not merely form a passive barrier. Instead, they actively control when and under which conditions immune cells leave the bloodstream and enter inflamed tissue. Tie1 cleavage is an early vascular event that facilitates the entry of circulating immune cells into inflamed tissue.

"The discovery shows how a single signaling pathway can regulate different functions of the vasculature," explains study leader Singhal. "Tie1 cleavage creates a functional separation between the regulation of vascular growth and vascular inflammation."

"The discovery shows that the different functions of the endothelium can be regulated more precisely and independently than we previously thought," says lead scientist Augustin. "It raises new questions about how such functional separation is organized in other endothelial processes."

Publication details

Miki Kamiyama et al, Tie1 ectodomain cleavage governs vascular responses to inflammatory stimulation but is dispensable for angiogenic signaling, Journal of Clinical Investigation (2026). DOI: 10.1172/jci204085

Journal information: Journal of Clinical Investigation

Key medical concepts

vascular inflammations

Clinical categories

Cardiology Provided by University of Mannheim Who's behind this story?

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Alexander Pol

PhD nano-engineering from Delft University. Published researcher and journal reviewer. Brings scientific insight to content standards. Full profile →

Citation: How blood vessels distinguish between growth and inflammation (2026, October 4) retrieved 4 October 2026 from https://medicalxpress.com/news/2026-10-blood-vessels-distinguish-growth-inflammation.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.